SAA1‐dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness

Ilona Rybinska,Nunzia Mangano,Sandra L. Romero‐Cordoba,Viola Regondi,Valentina Ciravolo,Loris De Cecco,Elisa Maffioli,Biagio Paolini,Francesca Bianchi,Lucia Sfondrini,Gabriella Tedeschi,Roberto Agresti,Elda Tagliabue,Tiziana Triulzi

DOI: https://doi.org/10.1002/ijc.34859

2024-02-01

International Journal of Cancer

Abstract:What's new? Adipocytes are suspected of playing a role in breast cancer progression, with increasing evidence that adipocytes interact with tumor cells. Potential mechanisms underlying such interactions, however, remain unknown. Here, mechanisms of crosstalk involving adipocytes and triple negative breast cancer (TNBC) cells were investigated in vitro. Experiments identified serum amyloid A1 (SAA1) as a regulator of TNBC cell‐induced adipocyte modification. SAA1 expression in human TNBCs was associated with the expression of a cancer‐associated adipocyte signature and with aggressive tumor features found to be regulated by adipocytes in cellular models. The findings cast new light on relationships between adipocytes and TNBC progression. Triple negative breast cancers (TNBC) are characterized by a poor prognosis and a lack of targeted treatments. Their progression depends on tumor cell intrinsic factors, the tumor microenvironment and host characteristics. Although adipocytes, the primary stromal cells of the breast, have been determined to be plastic in physiology and cancer, the tumor‐derived molecular mediators of tumor‐adipocyte crosstalk have not been identified yet. In this study, we report that the crosstalk between TNBC cells and adipocytes in vitro beyond adipocyte dedifferentiation, induces a unique transcriptional profile that is characterized by inflammation and pathways that are related to interaction with the tumor microenvironment. Accordingly, increased cancer stem‐like features and recruitment of pro‐tumorigenic immune cells are induced by this crosstalk through CXCL5 and IL‐8 production. We identified serum amyloid A1 (SAA1) as a regulator of the adipocyte reprogramming through CD36 and P2XR7 signaling. In human TNBC, SAA1 expression was associated with cancer‐associated adipocyte infiltration, inflammation, stimulated lipolysis, stem‐like properties, and a distinct tumor immune microenvironment. Our findings constitute evidence that the interaction between tumor cells and adipocytes through the release of SAA1 is relevant to the aggressiveness of TNBC.

oncology